欧阳雪宇, 王文杰, 廖文辉, 陈晓红. 银杏内酯B对慢性炎症血管生成的抑制作用J. 药学学报, 2005, 40(4): 311-315.
引用本文: 欧阳雪宇, 王文杰, 廖文辉, 陈晓红. 银杏内酯B对慢性炎症血管生成的抑制作用J. 药学学报, 2005, 40(4): 311-315.
OU-YANG Xue-yu, WANG Wen-jie, LIAO Wen-hui, CHEN Xiao-hong. Inhibitory effect of ginkgolide B on angiogenesis in chronic inflammationJ. Acta Pharmaceutica Sinica, 2005, 40(4): 311-315.
Citation: OU-YANG Xue-yu, WANG Wen-jie, LIAO Wen-hui, CHEN Xiao-hong. Inhibitory effect of ginkgolide B on angiogenesis in chronic inflammationJ. Acta Pharmaceutica Sinica, 2005, 40(4): 311-315.

银杏内酯B对慢性炎症血管生成的抑制作用

Inhibitory effect of ginkgolide B on angiogenesis in chronic inflammation

  • 摘要: 目的研究银杏内酯B对慢性炎症血管生成的作用及部分作用机制。方法比色法测定小鼠慢性肉芽肿气囊模型血管生成指数,组织形态学方法检测气囊病理变化;放射免疫方法测定白介素-1β(IL-1β)含量;L929生物测定法测定肿瘤坏死因子(TNF-α)含量;RT-PCR法检测IL-1β和TNF-α mRNA的表达。结果银杏内酯B可显著抑制模型小鼠的血管指数,与病理观察结果相符;银杏内酯B可显著抑制模型小鼠血清中IL-1和TNF-α的分泌;能显著抑制PMA诱导的U937细胞IL-1β和TNF-α的分泌及其mRNA的表达。结论银杏内酯B能抑制小鼠慢性炎症性血管生成模型的血管生成,能抑制促血管生成细胞因子IL-1β和TNF-α的转录及表达,这可能是其抑制慢性炎症血管生成的机制之一。

     

    Abstract: AimTo investigate the inhibitory effect of ginkgolide B on angiogenesis in chronic inflammation and the possible mechanisms. MethodsThe murine chronic granulomatous air pouch model was used to observe the anti-angiogenesis effect of ginkgolide B. The vascular index was determined by colorimetry of carminic acid, and angiogenesis was observed by histology method. The interleukin-1β (IL-1β) levels in mice serum and in supernatants of U937 cell culture stimulated by phorbol 12-myristate 13-acetate (PMA) were detected by radioimmunoassay (RIA). The tumor necrosis factor-α (TNF-α) levels in mice serum and in supernatant of U937 cell culture were measured by cytotoxicity bioassay. The mRNA expression of IL-1β and TNF-α of U937 cell culture was investigated by RT-PCR. ResultsOral administration of ginkgolide B 25 and 100 mg·kg-1 was shown to significantly inhibit the vascular index of murine chronic granulomatous air pouch model with the inhibitory rate of 22.52% and 25.29%, respectively. This result was supported by histological observation. Concomitantly, the IL-1β levels in mice serums were also significantly decreased with the inhibitory rate of 50.61% and 58.66%; so were the TNF-α levels with the inhibitory rate of 28.91% and 52.41%. Ginkgolide B at concentration of 1×10-5 to 1×10-8 mol·L-1 could also reduce both the IL-1β and TNF-α contents in the supernatants of U937 cell culture stimulated by PMA, but the scopes of changes were much different. For IL-1β the IC50 was 1.93×10-8 mol·L-1, while ginkgolide B at concentration of 1×10-5 mol·L-1 only decreased the release of TNF-α by 25.99%. Furthermore, ginkgolide B at concentrations of 1×10-5 to 1×10-7 mol·L-1 was shown to significantly inhibit TNF-α mRNA expression of U937 cells; and at concentrations of 1×10-5 and 1×10-6 mol·L-1 could inhibit IL-1β mRNA expression. ConclusionGinkgolide B was shown to significantly inhibit angiogenesis of the murine chronic granulomatous air pouch model, reduce the IL-1β and TNF-α levels in mice serums, and significantly inhibit IL-1β and TNF-α mRNA expression and protein secretion in supernatants of U937 cell culture. It was suggested that reduction of proangiogenic cytokines IL-1β and TNF-α secretion may contribute to the anti-angiogenesis effect of ginkgolide B in the murine chronic granulomatous air pouch model.

     

/

返回文章
返回